Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Homozygous EXOSC3 mutation c.92G→C, p.G31A is a founder mutation causing severe pontocerebellar hypoplasia type 1 among the Czech Roma

J. Schwabova, DS. Brozkova, B. Petrak, M. Mojzisova, K. Pavlickova, J. Haberlova, L. Mrazkova, P. Hedvicakova, L. Hornofova, M. Kaluzova, F. Fencl, M. Krutova, J. Zamecnik, P. Seeman,

. 2013 ; 27 (4) : 163-169.

Language English Country England, Great Britain

Document type Case Reports, Journal Article, Research Support, Non-U.S. Gov't

Grant support
NT14348 MZ0 CEP Register

Pontocerebellar hypoplasia type 1 (PCH1) is characterized by cerebellar and anterior horn motor neuron degeneration and loss, signs of spinal muscular atrophy plus. Patients manifest severe perinatal weakness, hypotonia, and respiratory insufficiency, causing death frequently before the age of 1 year. Recently, causative mutations in EXOSC3 were reported in a majority of PCH1 patients, but the detailed clinical phenotype caused by EXOSC3 mutations, genotype-phenotype correlations, and prevalent mutations in specific ethnic groups is not yet known. Three unrelated Czech Roma patients with PCH1 were investigated clinically, electrophysiologically, neuroradiologically, and neuropathologically (patients 1 and 2). The entire coding region of the EXOSC3 gene, including the adjacent intron sequences, was sequenced in all three patients. The same mutation c.92G→C, p.G31A in EXOSC3 was found in all three affected patients in homozygous state and in heterozygous state in the parents from two of the families. Haplotype analysis with four flanking microsatellite markers showed identical haplotype in 9 out of 11 haplotypes carrying the c.92G→C, p.G31A mutation. Furthermore, four heterozygotes for this mutation were found in anonymous DNA samples from 90 unrelated Roma individuals. All four of these samples shared the same haplotype. No heterozygous sample was found among 120 anonymous DNA samples from Czech non-Roma individuals with no familial relation. It may therefore be concluded that EXOSC3 c.92G→C, p.G31A mutation is a founder mutation with high prevalence among the Czech Roma causing a similar and particularly severe phenotype of PCH1. These observations from the Czech Roma may have consequences also for other Roma from other countries. PCH1 caused by EXOSC3 founder mutation c.92G→C, p.G31A extends the list of autosomal recessive disorders rare among the general population but more frequent among Roma at least in the Czech Republic.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc14074707
003      
CZ-PrNML
005      
20181030104316.0
007      
ta
008      
141006s2013 enk f 000 0|eng||
009      
AR
024    7_
$a 10.3109/01677063.2013.814651 $2 doi
035    __
$a (PubMed)23883322
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Schwabová, Jaroslava $u Department of Child Neurology, Charles University in Prague-2nd Faculty of Medicine and University Hospital Motol , Prague , Czech Republic. $7 xx0135926
245    10
$a Homozygous EXOSC3 mutation c.92G→C, p.G31A is a founder mutation causing severe pontocerebellar hypoplasia type 1 among the Czech Roma / $c J. Schwabova, DS. Brozkova, B. Petrak, M. Mojzisova, K. Pavlickova, J. Haberlova, L. Mrazkova, P. Hedvicakova, L. Hornofova, M. Kaluzova, F. Fencl, M. Krutova, J. Zamecnik, P. Seeman,
520    9_
$a Pontocerebellar hypoplasia type 1 (PCH1) is characterized by cerebellar and anterior horn motor neuron degeneration and loss, signs of spinal muscular atrophy plus. Patients manifest severe perinatal weakness, hypotonia, and respiratory insufficiency, causing death frequently before the age of 1 year. Recently, causative mutations in EXOSC3 were reported in a majority of PCH1 patients, but the detailed clinical phenotype caused by EXOSC3 mutations, genotype-phenotype correlations, and prevalent mutations in specific ethnic groups is not yet known. Three unrelated Czech Roma patients with PCH1 were investigated clinically, electrophysiologically, neuroradiologically, and neuropathologically (patients 1 and 2). The entire coding region of the EXOSC3 gene, including the adjacent intron sequences, was sequenced in all three patients. The same mutation c.92G→C, p.G31A in EXOSC3 was found in all three affected patients in homozygous state and in heterozygous state in the parents from two of the families. Haplotype analysis with four flanking microsatellite markers showed identical haplotype in 9 out of 11 haplotypes carrying the c.92G→C, p.G31A mutation. Furthermore, four heterozygotes for this mutation were found in anonymous DNA samples from 90 unrelated Roma individuals. All four of these samples shared the same haplotype. No heterozygous sample was found among 120 anonymous DNA samples from Czech non-Roma individuals with no familial relation. It may therefore be concluded that EXOSC3 c.92G→C, p.G31A mutation is a founder mutation with high prevalence among the Czech Roma causing a similar and particularly severe phenotype of PCH1. These observations from the Czech Roma may have consequences also for other Roma from other countries. PCH1 caused by EXOSC3 founder mutation c.92G→C, p.G31A extends the list of autosomal recessive disorders rare among the general population but more frequent among Roma at least in the Czech Republic.
650    _2
$a exozom $x genetika $7 D063326
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a Romové $x genetika $7 D006178
650    _2
$a haplotypy $7 D006239
650    _2
$a homozygot $7 D006720
650    _2
$a lidé $7 D006801
650    _2
$a kojenec $7 D007223
650    _2
$a novorozenec $7 D007231
650    _2
$a mužské pohlaví $7 D008297
650    12
$a mutace $7 D009154
650    _2
$a olivopontocerebelární atrofie $x genetika $7 D009849
650    _2
$a fenotyp $7 D010641
650    _2
$a proteiny vázající RNA $x genetika $7 D016601
650    _2
$a polymerázová řetězová reakce s reverzní transkripcí $7 D020133
651    _2
$a Česká republika $7 D018153
655    _2
$a kazuistiky $7 D002363
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Šafka-Brožková, Dana, $d 1981- $7 xx0100859
700    1_
$a Petrák, Bořivoj $7 xx0082041
700    1_
$a Exnerová, Mahulena $7 xx0258669
700    1_
$a Pavlickova, Klara
700    1_
$a Haberlová, Jana $7 xx0077362
700    1_
$a Mrázková, Lenka, $d 1973- $7 osa2011655325
700    1_
$a Hedvičáková, Petra $7 xx0065451
700    1_
$a Hornofová, Ludmila $7 xx0248458
700    1_
$a Kaluzova, Marie
700    1_
$a Fencl, Filip $7 xx0106176
700    1_
$a Krůtová, Marcela $7 xx0191653
700    1_
$a Zámečník, Josef, $d 1974- $7 xx0037787
700    1_
$a Seeman, Pavel, $d 1966- $7 xx0037870
773    0_
$w MED00002831 $t Journal of neurogenetics $x 1563-5260 $g Roč. 27, č. 4 (2013), s. 163-169
856    41
$u https://pubmed.ncbi.nlm.nih.gov/23883322 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20141006 $b ABA008
991    __
$a 20181030104832 $b ABA008
999    __
$a ok $b bmc $g 1042590 $s 873619
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2013 $b 27 $c 4 $d 163-169 $i 1563-5260 $m Journal of neurogenetics $n J Neurogenet $x MED00002831
GRA    __
$a NT14348 $p MZ0
LZP    __
$a Pubmed-20141006

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...